A case of nephrotic syndrome developing during postoperative gamma interferon therapy for renal cell carcinoma

Nephron

Volumn 73, Issue 4, 1996, Pages 685-688

  Tashiro, Michiko ^a,b   Yokoyama, Keitaro ^a   Nakayama, Masaaki ^a   Yamada, Akira ^a   Ogura, Yousuke ^a   Kawaguchi, Yoshindo ^b   Sakai, Osama ^b  

^a TORANOMON HOSPITAL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gamma interferon; Minimal change nephrotic syndrome; Nephrotic syndrome; Renal cell carcinoma

Indexed keywords

EID: 0029736851     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189160     Document Type: Article

References (25)

1. Eagen JW. Lewis EJ: Glomerulopathies of neoplasia. Kidney Int 1977:11:297-306.
2. Dabbs DJ. Striker LMM. Mignon F. Striker G: Glomerular lesion in lymphomas and leukc-mias. Am J Med 1986:80:63-70.
3. Quesada JR. Talpaz M. Rios A. Kurrock R. Gutterman JU: Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 1986; 4:234-243.
4. McCanse LRA. Moore JD. Markel L. Mcbust WK: Renal cell carcinoma presenting with nephrotic syndrome: A case report and review of the literature. J Urol 1975:114:938.
5. Dupond JL. Apffel F. Colas JM. Des Floris RL: Syndrome néphrotique à lésions glomérulaircs minimes révélateur d'un cancer du rein. Nouv Presse Méd 1980:9:884.
6. Forland M. Bannayan GA: Minimal-change lesion nephrotic syndrome with renal oncocytoma Am J Med 1983:75:715.
7. Nair S. Emstoff MS. Bahnson RR. Arthur S. Johnston J, Downs MA, Neuharl J. Kirkwood JM: Interferon-induced reversible acute renal failure with nephrotic syndrome. Urology 1992:39:169-172.
8. Lee SJ. Richards NT: Nephrotic syndrome cured by renal biopsv. Nephrol Dial Transplant 1992:7:265.
9. Abouchacra S. Duguid WP. Somerville PJ: Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure. Clin Nephrol 1993;39:340-342.
10. Tan YO. Woo KT. Chiang GCS. Pwec MS. Yco PPB. Khoo OT: Nephrotic syndrome associated with malignant tumors. Ann Acad Med Singapore 1982:11:57-60.
11. Mignon F. Beaufils H. Morel-Marogcr L, Clau-vcl JP. Valla D, Aubert PH: Glomérulopathics au cours des affections malignes; in Kus R. Lcgrain M (eds): Séminaires d'Uronéphrologie. Paris, Masson, 1982, pp 171-193.
12. Moorthy AV: Minmal change glomerular disease: A paraneoplastic syndrome in two patients with bronchogenic carcinoma. Am J Kidney Dis 1983;3:58-62.
13. Singer ChRJ, Boulton-Jones JM: Minimal change nephropathy associated with an anaplastic carcinoma of bronchus. Posgrad Med J 1986:62:213-217.
14. Mevrier A. Delahoussc M. Callard P. Rainfray M: Minimal change nephrotic syndrome revealing solid tumors. Nephron 1992:61:220-223.
15. Lee JZ, Yamauchi H. Hopper J: The association of cancer and nephrotic syndrome. Ann Intern Med 1966;64:41-51.
16. Caruana RJ. Griffin JW: Nephrotic syndrome in a patient with ulcerative colitis and colonic carcinoma. Am J Gastroenterol 1980:74:525-528.
17. Hiromura K. Fukushima Y. Tukada Y. Kanai H. Maezawa A. Yano S. Naruse T: Nephrotic syndrome associated with liver metastasis of renal cancer. Nephron 1995:69:485-486.
18. Hulter HN. Bonner EL: Lipid nephrosis appearing as acute oliguric renal failure. Arch Intent Med 1980;140:403-405.
19. Million D. Molho M. Oberlin P. Felsenheld C. Bruet A, Fendcrl JP: Syndrome nephrotique ä lesions glomerulaires minimes corticosensiblcs revclatcur d'un sarcome chordoidc. Ann Med Interne (Paris) 1984:135:274-277.
20. Schroctcr NJ. Rushing DA. Parker JP. Beltaos E: Minimal-change nephrotic syndrome associated with malignant mesothelioma. Arch Intern Med 1986;146:1834-1836.
21. Whdan TV. Hirszel P: Minimal-change nephropathy associated with pancreatic carcinoma. Arch Intern Med 1988;148:975-976.
22. Rapoport J. Kuperman O, Gopas Y. Maor E, Mostovslavski M, Abuful A, Chaimovitz C: Nephrotic syndrome associated with transitional cell carcinoma of the bladder. Nephron 1989:52:36-39.
23. Marlines AV. Panisello JM. Garcia C. Cases A. Torras A. Mayayo E. Carrera M. Richart C. Oliver JA: Minimal-change glomerulopathy and carcinoma. Am J Nephrol 1993:13:69-72.
24. Kurzrock R. Qucsada JR. Talpez M. Hersh EM, Reuben JM. Sherwin SA. Gutterman JU: Phase 1 study of multiple dose intramuscularly administered recombinant gamma interferon. J Clin Oncol 1986;4:1101-1109.
25. Aull BH, Stapleton FB. Gabcr L. Martin A. Roy S III. Murphy SB: Acute renal failure during therapy with recombinant human gamma interferon. N Engl J Med 1988:319:1397-1400.